What We Know (and Don’t) About Ozempic

Dual Impact Medication

Semaglutide, the active ingredient in Ozempic, is a GLP-1 receptor agonist. These medications mimic a hormone that regulates appetite and insulin production, aiding in blood sugar control and promoting weight loss.

Approved by the U.S. Food and Drug Administration (FDA) in 2017 for adults with type 2 diabetes, Ozempic has shown significant secondary effects in weight reduction. This has led to its off-label use for weight loss in individuals without diabetes, a trend amplified by social media and celebrity endorsements.

Side Effects: Common & Serious

Like any prescription drug, Ozempic has side effects ranging from mild to serious. Common symptoms include nausea, vomiting, diarrhea, abdominal pain and constipation, particularly when initiating treatment or increasing dosage.

More severe side effects have been reported, such as pancreatitis, gallbladder issues, kidney problems and a potential risk of thyroid tumors, notably medullary thyroid carcinoma. Although this cancer risk has primarily been observed in animal studies, individuals with a family history of thyroid cancer are advised against using Ozempic.

The medication is administered once weekly via subcutaneous injection, with patients typically starting at a lower dose to minimize gastrointestinal discomfort before gradually increasing to a maintenance level. 

Muscle Loss & Nutritional Concerns

While weight loss from semaglutide can be significant, health professionals caution that not all lost weight is beneficial. Research suggests that a portion of the weight loss may come from lean muscle mass, not just fat tissue, which could potentially impact long-term strength, mobility and metabolic health.

To mitigate this, experts recommend maintaining a balanced diet rich in protein and engaging in resistance training while on the medication. These practices help preserve muscle mass and support more sustainable outcomes.

What Happens When You Stop?

An often-overlooked aspect of Ozempic use is the potential for weight regain after discontinuation of the medication. Many patients report regaining weight once they stop taking the drug, especially if lifestyle changes are not firmly in place.

Ozempic is not a short-term solution and is designed to work in conjunction with behavioral changes. Both the manufacturer and medical experts agree that semaglutide should be part of a comprehensive treatment plan, including ongoing dietary improvements and regular physical activity. 

Shortages & Off-Label Pressure

In 2023, the FDA listed Ozempic as being in short supply due to its rising popularity for weight loss purposes. This shortage affected some individuals with type 2 diabetes who rely on the medication for chronic disease management.

The increased demand for off-label use has raised ethical concerns within the medical community. As new weight-loss-specific GLP-1 formulations, such as Wegovy, enter the market, these access issues may be alleviated, but discussions about equitable use will likely continue. 

A Promising Tool

For adults with type 2 diabetes or obesity-related health conditions, Ozempic can offer meaningful health improvements. However, for those considering it solely for cosmetic weight loss, medical professionals urge caution.

The long-term safety profile of semaglutide is still under study, particularly among individuals who do not meet the typical medical criteria for its use. Until more data is available, experts agree that it should be prescribed only under careful medical supervision, with a complete understanding of the potential risks and benefits.

Read more articles for the ConnectComm Community here.